Management of female infertility from hormonal causes

被引:17
|
作者
Luciano, Antony A. [1 ]
Lanzone, Antonio [2 ]
Goverde, Angelique J. [3 ]
机构
[1] Univ Connecticut, Sch Med, Ctr Fertil & Womens Hlth, New Britain, CT 06051 USA
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Univ Med Ctr Utrecht, Dept Reprod Med & Gynecol, Utrecht, Netherlands
关键词
Anovulation; Fertility restoration; Induction of mono-ovulation; Infertility; POLYCYSTIC-OVARY-SYNDROME; CLOMIPHENE CITRATE INDUCTION; OVULATION INDUCTION; THYROID-DISEASE; ANOVULATORY INFERTILITY; DOPAMINE AGONISTS; RISK-FACTORS; FOLLOW-UP; WOMEN; THERAPY;
D O I
10.1016/j.ijgo.2013.09.007
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Hormonal causes of female infertility involve ovulatory dysfunctions that may result from dysfunction of the hypothalamic-pituitary-ovarian axis, peripheral endocrine glands, nonendocrine organs, or metabolic disorders. It is important to think of anovulation not as a diagnosis but as a symptom of a metabolic or endocrine disorder that requires a thorough diagnostic evaluation to identify the specific cause and to implement effective therapies that assure the best possible pregnancy outcome and avoid long-term adverse health consequences. In most instances, the medical history points to the underlying dysfunction, which can usually be confirmed with laboratory or imaging tests. For more challenging cases, more extensive evaluations may be needed, including perturbation studies. Nevertheless, the management of anovulatory infertility is gratifying because its causes are often manifest and the treatment usually results in resumption of ovulatory cycles, restoration of fertility, and healthy offspring through natural conception without requiring expensive and intrusive assisted reproductive technologies. (C) 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S9 / S17
页数:9
相关论文
empty
未找到相关数据